Part of the prophylactic armoury against pandemic disease is a programme of surveillance for emergent pathogens. The current SARSCoV-2 outbreak may have been foresee...

Under new leadership, the US Food and Drug Administration (FDA) is now focusing efforts on closing the gap between scientific advances and the computing solutions ne...

With the rapidly evolving nature of the coronavirus (COVID-19) pandemic, configurability and adaptability are key for IRT systems in order to minimise the impact to ...

The FDA has created a special emergency programme for therapeutics known as the Coronavirus Treatment Acceleration Program (CTAP). This programme attempts to utilise...

COVID-19 is a new virus with its own characteristics and the human population has showed its naivety. The number of individuals infected with COVID-19 continues to r...

The definition of being truly patient-centric is simply allowing a patient to participate in a clinical trial with minimal disruption to their personal and family li...

Whilst pandemics are fortunately not common, the global impact of COVID-19 has been profound. At the time of writing, global deaths havereached 420,000 whilst over 7...

Employing Adaptive Approaches to Reach Desired Clinical Objectives The field of oncology is expanding and changing rapidly. With increasing advancements in genomi...

The World Health Organization (WHO) classification system for obesity is based on body mass index (BMI). A BMI of 25.0 to 29.9 kg/ m2 is considered overweight, and ≥...

Lung cancer is the leading cause of cancer death – 1.76 million lung cancer deaths occurred worldwide in 2018. More than 80% of patientswere presenting with non-smal...